Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rph-104 (1 trial)
olokizumab (1 trial)
Infarction (Phase 2)
Inflammation (Phase 2)
Myocardial Infarction (Phase 2)
ST Elevation Myocardial Infarction (Phase 2)
Trials (2 total)
Trial APIs (2 total)